pharmaceuticals

Recent Posts

EpiPen lobbying campaign targeted Connecticut

WASHINGTON – Connecticut, one of 11 states that approved a law requiring schools to stock EpiPens, is on drug maker Mylan’s sizable lobbying list. According to the center, Mylan, under fire for its steep price hikes of the EpiPen, expanded its lobbying presence in state houses to Connecticut and 35 additional states between 2010 to 2014. Continue Reading →

Filed under: , , , , , , ,

Blumenthal, others who helped sales of EpiPen, want probe of price hikes

WASHINGTON — Like other lawmakers who are now calling for an investigation of the massive price hikes in price hikes of EpiPens, Sen. Richard Blumenthal backed legislation that encouraged schools to stock the auto injector that delivers a drug that counters the effects of a fatal allergic reaction. Continue Reading →

Filed under: , , , , , , ,

Specialty drug prices threaten health care affordability

State Comptroller Kevin Lembo

The state employee health plan has tailored its design to encourage people to manage chronic conditions, get preventive care and avoid emergency room visits. But costs are being driven up by the rising expense of specialty drugs for conditions including Hepatitis C, multiple sclerosis and cancer. It’s a challenge that’s not unique to the state employee health plans, health care experts said Tuesday. Continue Reading →

Filed under: , , , , , , ,

CT lawmakers push back on pharmaceutical issue in TPP

WASHINGTON – As negotiators for a massive Pacific Rim trade pact meet in Maui for a final round of talks, Connecticut lawmakers are pressing for changes they say will keep the price of key medicines affordable for patients who need them overseas and in the United States. Continue Reading →

Filed under: , , , , , , ,